Market Overview

Akerna Shares Plunge After Q2 Print: Cannabis Tech Company Posts Higher Revenue, Wider Net Loss

Share:
Akerna Shares Plunge After Q2 Print: Cannabis Tech Company Posts Higher Revenue, Wider Net Loss

The cannabis regulatory compliance tech company Akerna Corp. (NASDAQ: KERNreleased second-quarter results Wednesday, posting revenue of $3.3 million, up 28% year-over-year. 

The increased revenue can be attributed to the persistent demand for Akerna's software product, MJ Platform, which saw a 29% revenue increase in the second quarter, according to the company.

Akerna’s gross profit margin reached 50% in the second quarter, which compares to 49% in the same period of 2018.

The company's second-quarter net loss amounted to $4.3 million, higher than $2.4 million in the same period last year.

Akerna had about $18.8 million in cash as of Dec. 31, 2019, the company said.

Among important business milestones that occurred in the second quarter, the company highlighted its strategic investment in ZolTrain and transactions to acquire Ample Organics and a majority interest in Solo Sciences.

Benzinga's Cannabis Capital Conference returns to Miami Feb. 24-25 with North America's largest B2B cannabis gathering, bringing together capital, cannabis executives, thought leaders and more!

“Our results for the quarter ended December 31, 2019, continue to be illustrative of the continued adoption of both MJ Platform and Leaf Data Systems by cannabis enterprises and government entities,” Akerna CEO Jessica Billingsley said in a statement.

“With cannabis legalization continuing to expand and our recent acquisitions of both solo sciences and Ample Organics, Akerna is well-positioned to serve the increasing compliance needs of enterprise cannabis companies, governments, and consumers. Transparency remains critical, as regulatory requirements will only grow to ensure public, product, and patient (or consumer) safety.”

Akerna shares were down 16.65% at $6.91 at the time of publication Thursday.

Related Links:

Akerna Inks Deal With PAX Labs For Transparency, Safety Tracking

The Week In Cannabis: Aurora's Roller Coaster Ride, USDA's Hemp Moves, MJ's Dividend And More

Akerna CEO Jessica Billingsley. Benzinga file photo by Dustin Blitchok. 

Posted-In: Jessica Billingsley MJ PlatformCannabis Earnings News Markets Best of Benzinga

 

Related Articles (KERN)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!